Programs
Breast Cancer
Colorectal Cancers
ctDNA/MRD
Genitourinary Cancers
GI Cancers
Biliary Tract Cancers
Gastroesophageal Cancers
Liver Cancer
Pancreatic Cancer
Gynecologic Cancer
Hematologic Cancers
Lung Cancer
Melanoma
Precision Medicine
ALK
BRAF
BRCA
c-MET
EGFR
ESR1
FGFR
HER2
KRAS
MTAP
NRG1 Fusions
NTRK Fusions
Faculty
Tumor Boards
Newsletters
Resources
About Us
Search
Breast Cancer
Unmasking Resistance: Rising ctDNA and ESR1 Mutation in Early-Stage HR+ Breast Cancer
Jason A. Mouabbi, MD
Evolving Management of HER2 Low and Ultralow Breast Cancer
Adrienne G. Waks, MD
ctDNA and MRD Assessment in Breast Cancer
Jason A. Mouabbi, MD
STMI-NTRK mutated Metastatic Breast Cancer
Martin F. Dietrich, MD, PhD
Evolving Role of ADCs in Managing Advanced Breast Cancer
Adrienne G. Waks, MD
Understanding HER2 Low Breast Cancer
Adrienne G. Waks, MD
BRCA-Positive Early-stage Breast Cancer: Treatment and Testing
Reshma L. Mahtani, DO
Previous Page
1
2
Loading Comments...
Write a Comment...
Email (Required)
Name (Required)
Website